AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
ConjunctivitisConjunctivitis, BacterialConjunctivitis, AllergicNew OrleansConjunctivitis, ViralFloodsConjunctivitis, InclusionCyclonic StormsConjunctivitis, Acute HemorrhagicLaw EnforcementStreet DrugsDrug and Narcotic ControlCommerceConjunctivaHeroin DependenceCrack CocaineCrimeMultilevel AnalysisAmbrosiaEnterovirus C, HumanOphthalmia NeonatorumSocial EnvironmentTaxesKeratoconjunctivitisBlepharitisDisastersOphthalmic SolutionsEconomic CompetitionTearsAdenoviridae InfectionsCocaine-Related DisordersAdenovirus Infections, HumanPopulation DynamicsHealth Care SectorResidence CharacteristicsChlamydophila psittaciFinancial Management, HospitalIritisTrachomaAdministration, TopicalSubstance-Related DisordersFinancial ManagementChlamydia trachomatisFees, DentalEye DiseasesPsittacosisEconomics, HospitalEnterovirusFees and ChargesMarketing of Health ServicesUncompensated CareCryptomeriaConjunctival DiseasesInvestmentsTax ExemptionDisease OutbreaksUnited StatesTobacco IndustryIncome TaxPollenFinancing, GovernmentCost AllocationMarketingChlamydia InfectionsProvider-Sponsored OrganizationsIncomeEye HemorrhageHistamine H1 AntagonistsBudgetsCosts and Cost AnalysisAnti-Allergic AgentsModels, EconometricHealth Care ReformChlamydiaceae InfectionsAccountingAllergensHealth Facility MergerModels, EconomicGenital Diseases, FemaleSilver NitrateDental ClinicsDrug IndustryInsurance, Health, ReimbursementInfluenza A Virus, H7N3 SubtypeChlamydiaContract ServicesAdenoviruses, HumanEnterovirus InfectionsEnterovirus D, HumanManaged CompetitionInflation, EconomicCapital ExpendituresEye Infections, BacterialInfluenza A Virus, H7N7 SubtypeRestaurantsSalaries and Fringe BenefitsCost ControlPrivatizationHealth ExpendituresInfant, Newborn
Itching associated with allergic conjunctivitisAllergic Conjunctivitis MarketCAGR2022OphthalmicNorth AmericaInsightsGrowthUveitisBlepharitis2023GlaucomaTrendsHealthcare2021PrevalenceAntihistaminesPharmaReproxalapInvestigational new drug candiBacterialPandemicDextenzaAntihistamine drugsOcular TherapeutixShareSizeFactorsAldehydeLANDSCAPEAnalysisTreatmentChallengesOphthalmologyOutlookAcuteDevelopmentOutbreak of COVID-19PHARMACEUTICALDemandGlobalCommonly2020BepreveTherapiesTherapeuticsTabletsRegulatoryProductExclusivityHospital PharmaciesREPORTPrimarilyPatientsExpendituresApplication
Itching associated with allergic conjunctivitis3
  • He also spoke of strong market share growth for Bepreve (bepotastine), an eye drop for ocular itching associated with allergic conjunctivitis. (pharmatimes.com)
  • DEXTENZA ® is currently approved in the U.S. for the treatment of ocular inflammation and pain following ophthalmic surgery and for the treatment of ocular itching associated with allergic conjunctivitis. (ocutx.com)
  • Ocular Therapeutix's first commercial drug product, DEXTENZA ® , is an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis. (ocutx.com)
Allergic Conjunctivitis Market2
  • The global " Allergic Conjunctivitis " Market is projected to gain significant revenue in the coming years on account of the increasing awareness about availability of these drugs. (thepostrecords.com)
  • Allergic Conjunctivitis Market, Global Forecast Treated Patients By Countries, Disease Type, Pipeline Drugs, Company Analysis (MoneyNewsWire.Net, February 01, 2021 ) Allergic conjunctivitis is common ophthalmic disorder caused by reactions to allergens like pollen or mold spores, dust mites and. (moneynewswire.net)
CAGR8
  • Based on the acromegaly and gigantism drugs market insights, this market will register a CAGR of about 3% during the forecast period. (technavio.com)
  • Global " Electronic Manufacturing Services Market " 2022 report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, and Business Revenue Status of Top Key Players and Drivers. (semiconductorsindustry.com)
  • The market is projected to grow from USD 504.22 billion in 2022 to USD 797.94 billion by 2029, exhibiting a CAGR of 6.8% during the forecast period. (semiconductorsindustry.com)
  • The 7 major bacterial conjunctivitis markets are expected to exhibit a CAGR of 3.36% during 2023-2033. (imarcgroup.com)
  • The global ophthalmic packaging market was valued at USD 6.64 billion in 2021 and is expected to grow at a CAGR of 12.0% during the forecast period. (polarismarketresearch.com)
  • The Dry Eye Syndrome Market size is expected to be worth around USD 7,940 Million by 2032 from USD 4,540 Million in 2022 , growing at a CAGR of 5.9% during the forecast period from 2023 to 2032. (market.us)
  • Global Antihistamines Market is projected to increase at a significant CAGR of 9.50% in the coming years. (credenceresearch.com)
  • NEWARK, Del, Nov. 20, 2023 (GLOBE NEWSWIRE) - According to the most recent industry data by Future Market Insights, the global antihistamine market was valued at approximately US$ 263.9 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% over the forecast period. (forextv.com)
202212
  • The presence of a strong pipeline will be one of the primary factors driving the acromegaly and gigantism drugs market growth until 2022. (technavio.com)
  • Prescription drugs are expected to be the fastest-growing segment in 2022. (cbinsights.com)
  • North America led the market in 2022, with 38.9% of the revenue. (market.us)
  • North America dominated the market in 2022 due to a large target population and better healthcare access. (market.us)
  • Due to the high prevalence of the disease, which can be linked to factors such as a reduced rate of blinking, an increase in screen time, and reduced tear formation due to age, evaporative dry eye syndrome dominated the market in 2022 with the largest revenue share. (market.us)
  • LEXINGTON, Mass. --(BUSINESS WIRE)--Nov. 29, 2022-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for topical ocular reproxalap, an investigational new drug candidate, for the treatment of signs and symptoms of dry eye disease. (aldeyra.com)
  • It is presumed to generate revenue opportunities for the key industry players worth USD 156.26 million during the forecast period between 2022 and 2028. (credenceresearch.com)
  • In 2022, H-1 accounted for the highest market share of 55.9% in the antihistamine market. (forextv.com)
  • Tablets accounted for 35.0% of the market share in 2022. (forextv.com)
  • In 2022, the allergies segment led the indication category, accounting for 38.1% of the market. (forextv.com)
  • While AI-based medical imaging and diagnostics had the most applications in 2022, AI-based drug discovery saw a decline, possibly due to technology maturation or concerns over patentability. (substack.com)
  • The value of the domestic market for pharmaceuticals is expected to grow by 4.5-5.0% in 2022 relative to the 2021 figure , thanks to the easing of fears about COVID-19 and the return of the Thai economy to somewhere close to its normal level, with the subsequent rebound in growth then feeding into stronger spending power. (pakgon.com)
Ophthalmic11
  • Nicox generates revenue from VYZULTA(R) in glaucoma and ZERVIATE(TM), or cetirizine ophthalmic solution, in allergic conjunctivitis. (wikipedia.org)
  • In 2019, Nicox and Ocumension Therapeutics signed an agreement to allow Ocumension the rights to develop and commercialize Zerviate, a cetirizine ophthalmic solution, for the Chinese and South East Asian markets. (wikipedia.org)
  • Taiwan Liposome Company (TLC) is a biopharmaceutical company engaging in research, development and commercialization of proprietary drug delivery system for improving the treatment of cancer, ophthalmic conditions, and infectious diseases. (cbinsights.com)
  • Some of the drugs available in this market are Lotemax gel/ointment, Zylet, Durezol, Bepreve (bepotastine besilate ophthalmic solution), and prescription artificial tears. (cbinsights.com)
  • Bacterial conjunctivitis, commonly called pink eye, refers to an infectious ophthalmic condition caused by various bacteria, primarily staphylococci and streptococci. (imarcgroup.com)
  • The demand for ophthalmic packing is rising owing to the increasing incidences of eye problems such as dry eye and conjunctivitis, as well as growing regulatory guidelines for recycling wrapping materials are attributed to the market growth across the globe. (polarismarketresearch.com)
  • In addition, increasing awareness regarding eye care, the growing population, and rapid technological developments are some further prominent factors that positively impact the ophthalmic packaging market growth in the upcoming years. (polarismarketresearch.com)
  • The outbreak of COVID-19 has affected every sector of the global economy, including the ophthalmic packaging market. (polarismarketresearch.com)
  • However, the market witnessed significant growth in the upcoming years due to the gradual opening of the lockdown and resumption of the clinics and hospital visits, which, in turn, may bring an upsurge in the global ophthalmic packaging market in the future scenario. (polarismarketresearch.com)
  • The growing incidences of ophthalmic conditions are one of the significant driving factors that accelerate the ophthalmic packaging market growth worldwide. (polarismarketresearch.com)
  • Factors such as increasing drug efficacy, stability, formulation, treatment duration, and single-dose are intended for the one-time use of ophthalmic products that contribute to the product demand. (polarismarketresearch.com)
North America6
  • Among all regions, North America emerged dominant owing to the strong prevalence of this conjunctivitis in the region, coupled with the increasing healthcare infrastructure and facilities. (thepostrecords.com)
  • Another major reason was the shutdown of the plants and factories in key production regions such as Asia, North America and Europe in the later quarter of 2020 that reduced the scale of production in the market. (businessresearchinsights.com)
  • The market share for Antihistamines in North America is the largest in the United States in 2021. (credenceresearch.com)
  • North America region had a major share in terms of volume and value in the global Antihistamines market in 2021 and is projected to continue its dominance over the forecast period. (credenceresearch.com)
  • North America is Expected to Hold a Significant Share in the Market Over the Forecast Period. (forextv.com)
  • North America is considered the leading segment by region, with a market share of 35.0% at the end of the forecast period. (forextv.com)
Insights5
  • Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. (semiconductorsindustry.com)
  • Global Rehabilitation Training Robotics Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. (cognitivemarketresearch.com)
  • Rehabilitation Training Robotics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. (cognitivemarketresearch.com)
  • Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. (futurewiseresearch.com)
  • Future Market Insights, Inc. (forextv.com)
Growth44
  • Will the expanded indication be a big growth driver, or should investors be looking at drugs in the pipeline, which seem like they're still pretty early-stage? (fool.com)
  • According to our analysts, this is one of the key trends that will stimulate the growth of the acromegaly and gigantism drugs market size and share. (technavio.com)
  • By offering a complete analysis of the market's competitive landscape and with information on the products offered by the companies, this acromegaly and gigantism drugs industry analysis report is designed to aid clients identify new growth opportunities and design innovative strategies for strengthening their position in the market. (technavio.com)
  • The somatostatin analogs segment will account for the highest growth in the market. (technavio.com)
  • Additionally, the report will also provide an accurate prediction of the contribution of the various drug class segments to the growth of the acromegaly and gigantism drugs market size. (technavio.com)
  • At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles. (thepostrecords.com)
  • Electronic Manufacturing Services Market size report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. (semiconductorsindustry.com)
  • The Covid-19 pandemic favored the growth of the market due to a rise in the shift toward the adoption of technologies since most businesses implemented the work-from-home culture. (semiconductorsindustry.com)
  • Market drivers help you understand the impact on market growth. (cognitivemarketresearch.com)
  • Market Restraints of Rehabilitation Training Robotics: Restraints are the negative factors which hinder the market growth and development in the near future. (cognitivemarketresearch.com)
  • Some of the restraining factors including strict government regulations, supply chain disruptions, changing consumer preference are affecting the market growth in the near future. (cognitivemarketresearch.com)
  • Restraining factors are important to analyse on account of companies can develop strategies to overcome their negative impact on the growth of the market. (cognitivemarketresearch.com)
  • Market Opportunities of Rehabilitation Training Robotics: Market opportunities are expected to open up growth window for the new entrants in the market. (cognitivemarketresearch.com)
  • Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. (cognitivemarketresearch.com)
  • The nano-particle drug delivery systems segment is expected to witness the highest growth rate during the forecast period. (cbinsights.com)
  • The pescription drugs segment is expected to witness the highest growth rate during the forecast period. (cbinsights.com)
  • The growth of the prescription drug industry is due to the rise in diseases including AMD and diabetic retinopathy. (cbinsights.com)
  • The Bedford, Mass.-based ophthalmology drug delivery company posted losses of -$8.5 million on sales of $11.7 million for the three months ended June 30, 2021, for a 76.8% bottom-line gain on sales growth of more than six times last year's second-quarter tally. (drugdeliverybusiness.com)
  • Moreover, the widespread adoption of hygiene and preventive measures, given their role in averting bacterial transmission and reducing the likelihood of conjunctival infections, is further bolstering the market growth. (imarcgroup.com)
  • Additionally, the emerging popularity of lubricating artificial tears that help to alleviate symptoms and maintain ocular moisture in individuals suffering from this ailment is also augmenting the market growth. (imarcgroup.com)
  • The rising adoption of multi-dose containers in the OTC market is a major driving factor for product growth. (polarismarketresearch.com)
  • Factors driving market growth include a higher incidence of dry eyes, a growing pipeline of treatments, and increased awareness. (market.us)
  • Rising cases of dry eye disease, especially in older people, contribute to market growth. (market.us)
  • Older people producing fewer tears and increased awareness contribute to market growth. (market.us)
  • The industry analysis report is considered a valuable source of information about the global Bacterial Conjunctivitis Treatment industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years. (mynextmatch.com)
  • A substantial increase in demand for healthcare services worldwide, rising cases of the SARS-CoV-2 infection, increasing pharmaceutical research development activities, and new drug pipelines are among the key factors that have driven the global pharma healthcare industry growth in the recent past. (mynextmatch.com)
  • What is the revenue growth rate of the global Bacterial Conjunctivitis Treatment market over the forecast period? (mynextmatch.com)
  • What are the major factors driving the growth of the Global Bacterial Conjunctivitis Treatment Market? (mynextmatch.com)
  • What are the key challenges impacting the global Bacterial Conjunctivitis Treatment market growth? (mynextmatch.com)
  • All the new developments have paved the path for the market growth. (businessresearchinsights.com)
  • These are the major factors driving the market growth. (businessresearchinsights.com)
  • Greater production leads to higher sales which in return increases the market growth. (businessresearchinsights.com)
  • This factor has propelled the market growth in the recent times. (businessresearchinsights.com)
  • This factor has driven the market growth and polymixin market share. (businessresearchinsights.com)
  • FutureWise Market Research has instantiated a report that provides an intricate analysis of Eye Infections Treatment Market trends that shall affect the overall market growth. (futurewiseresearch.com)
  • According to the research study conducted by FutureWise research analysts, the Eye Infections Treatment Market is anticipated to attain substantial growth by the end of the forecast period. (futurewiseresearch.com)
  • This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. (futurewiseresearch.com)
  • The aging population's expansion will also enhance the market's growth rate and the creation of cutting-edge drug solutions for treating allergic diseases are the major factors driving the market's growth. (credenceresearch.com)
  • The market for antihistamine medications will face challenges due to the absence of healthcare infrastructure in developing economies, and high implementation costs are projected to hinder the growth of the Antihistamines market over the forecast period. (credenceresearch.com)
  • Accelerating Growth in Antihistamines Market Rising Usage of Anti-inflammation Medications on a Global Level. (forextv.com)
  • This increasing demand would eventually have a positive impact on the growth of the antihistamines market. (forextv.com)
  • This further stimulates the demand for the antihistamine medications, which help in decreasing the effects of inflammation, owing to the growth of the market. (forextv.com)
  • However, the increasing prevalence of eye illnesses and disorders among youngsters has paved the way for future growth in the worldwide Eye Allergy Therapeutics Market. (verifiedmarketresearch.com)
  • Foodborne infections, dust mites, and other environmental factors can all contribute to the development of an eye infection and it leads to the growth of the Global Eye Allergy Therapeutics Market. (verifiedmarketresearch.com)
Uveitis2
  • Aldeyra has initiated clinical testing of NS2 for the treatment of Sjögren-Larsson Syndrome, noninfectious anterior uveitis, and allergic conjunctivitis. (redchip.com)
  • We also plan to evaluate its potential in benefiting patients with ocular neuropathic pain, uveitis and allergic conjunctivitis. (iposcoop.com)
Blepharitis2
20236
  • Share your contact details to receive free updated sample copy/pages of the recently published edition of Rehabilitation Training Robotics Market Report 2023. (cognitivemarketresearch.com)
  • Global Rehabilitation Training Robotics market size 2023 was XX Million. (cognitivemarketresearch.com)
  • Cognitive Market Research has recently published the 7th edition of Rehabilitation Training Robotics Market Report 2023. (cognitivemarketresearch.com)
  • In-market billable unit volumes were approximately 8% ahead of fourth quarter volumes, and we continue to guide towards a full year 2023 net product revenue of $55 to $60 million . (gcs-web.com)
  • Over 2023 to 2025, the market is expected to continue to grow thanks to the likely ongoing rise in incidences of chronic non-communicable diseases (NCDs), the extension of universal health coverage programs to cover the whole of the Thai population, the increasing number of foreign patients seeking treatment in Thai hospitals, and the rising global concerns with wellness and preventative healthcare that are influencing Thai consumers. (pakgon.com)
  • Over 2023 to 2025, the domestic market for pharmaceuticals is expected to grow on increasing rates of NCDs among the general population, the broader access to healthcare provided for by the Universal Coverage Scheme, the greater number of overseas patients seeking treatment in Thai hospitals, and global trends that are encouraging greater consumer interest in wellness and preventative healthcare. (pakgon.com)
Glaucoma3
  • Bimatoprost is a prostaglandin analog, the most widely used class of drugs for IOP lowering in patients with open angle glaucoma and ocular hypertension. (wikipedia.org)
  • The drug class segment is anti-glaucoma, antiallergy, anti-VEGF agents, and anti-inflammatory. (cbinsights.com)
  • Glaucoma represents another large potential ophthalmology market where we believe our hydrogel technology, which we have branded as Elutyx™, has the potential to redefine the current standard of care. (gcs-web.com)
Trends8
  • In terms of drivers, opportunities, and constraints, the analysis provides info on developing trends and market dynamics. (semiconductorsindustry.com)
  • Market Trends of Rehabilitation Training Robotics: (This information will be part of the paid report version. (cognitivemarketresearch.com)
  • Get the latest news and trends happening now in drug delivery. (drugdeliverybusiness.com)
  • The study includes an overall analysis of the Global Bacterial Conjunctivitis Treatment Market and the study of its market trends to forecast the output for the coming years from 2020-2027. (mynextmatch.com)
  • The global pharma healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. (mynextmatch.com)
  • We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. (mynextmatch.com)
  • These have been some of the latest trends in the market. (businessresearchinsights.com)
  • The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. (verifiedmarketresearch.com)
Healthcare4
  • US healthcare giant Abbott has renamed the branded drugs part of its business following its decision to split that unit from the medical devices unit - creating two separate organisations. (chemistryworld.com)
  • The diagnosis of bacterial conjunctivitis typically involves a thorough eye examination by a healthcare professional. (imarcgroup.com)
  • MoneyNewsWire.Net, February 03, 2021 ) Top-down and bottom-up approaches were used to validate the size of the global Healthcare BPO market and estimate the size of various other dependent submarkets. (moneynewswire.net)
  • We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. (mynextmatch.com)
20219
  • The global electronic manufacturing services (EMS) market was valued at USD 476.88 billion in 2021. (semiconductorsindustry.com)
  • In the second half of 2021, we look forward to continued momentum with Dextenza, including a PDUFA date in allergic conjunctivitis in October, and further development of our pipeline which includes the expected completion of our Phase 2 clinical trial with OTX-CSI, our cyclosporine-containing intracanalicular insert for the chronic treatment of dry eye disease. (drugdeliverybusiness.com)
  • The multi-dose segment is the leading segment in terms of revenue generation in the year 2021 and is expected to dominate the market in forecast years. (polarismarketresearch.com)
  • Europe Online Food Delivery Market & User, Country, Company Analysis & Forecast (MoneyNewsWire.Net, February 01, 2021 ) Online food ordering market in Europe has grown multiple folds in the last five years. (moneynewswire.net)
  • Soybean Oil Market & Volume By Consuming, Producing, Importing, Exporting Country, Company Analysis & Global Forecast(MoneyNewsWire.Net, February 01, 2021 ) Soybean oil is a popular cooking oil that is used by consumers all across the globe. (moneynewswire.net)
  • MoneyNewsWire.Net, January 26, 2021 ) This report on the global market is analyzed and segmented on the basis of product, and region. (moneynewswire.net)
  • Paper Packaging Market By Product Type, End User, Regions, Company Analysis, & Global Forecast(MoneyNewsWire.Net, January 19, 2021 ) Paper and based materials are the most established and most adaptable types of packaging materials accessible in today s life. (moneynewswire.net)
  • Cassava Starch Market, Consumption & Global Forecast by Type, Region, Applications, Company Analysis(MoneyNewsWire.Net, January 19, 2021 ) Cassava is the increasingly popular feed material for starch extraction. (moneynewswire.net)
  • In 2021, the global Antihistamines market was valued at USD 215.9 Million and is projected to reach the value of USD 371.2 million by 2028. (credenceresearch.com)
Prevalence5
  • The Americas has always been a key market in the context of global acromegaly and gigantism drugs demand and this is mainly due to the high prevalence of the disease in the region. (technavio.com)
  • The market for eye drops is expected to develop as a result of the rising OTC availability of eye drops, patient compliance concerns, and the prevalence of eye diseases. (cbinsights.com)
  • The rising prevalence of eye disorders caused by the infiltration of harmful bacteria into the conjunctiva is primarily driving the bacterial conjunctivitis market. (imarcgroup.com)
  • The market is expanding as a result of a number of factors, including the rising prevalence of dry eye syndrome, the existence of a lucrative pipeline, and the growing public awareness of the condition. (market.us)
  • These symptoms are very basic and common ones, so their prevalence is quite high, owing to the increase in the demand for the antihistamine drugs. (forextv.com)
Antihistamines6
  • What is the Market Size of Antihistamines in term of value? (credenceresearch.com)
  • Who are the Top 10 players/companies in Antihistamines market in term of value and volume? (credenceresearch.com)
  • In order to increase their production of Antihistamines and capture a competitive market share on a global scale, these leading companies are focusing on new product advancements as well as technological innovation. (credenceresearch.com)
  • Antihistamines are medicines that are commonly used for relieving individuals experiencing common symptoms like running nose, sneezing, itchy throat, conjunctivitis, and others. (forextv.com)
  • Over-the-counter antihistamines hold the highest market share of 51.3% in the type category. (forextv.com)
  • Antihistamines play a very important role in the Global Eye Allergy Therapeutics Market due to Antihistamine tablets and liquids alleviate watery, itchy eyes by inhibiting histamine. (verifiedmarketresearch.com)
Pharma3
  • The new pharma company, to be launched by the end of 2012, will be called AbbVie, while the medical devices company - which will include the generic drugs and food supplements portfolio - will inherit the existing Abbott name. (chemistryworld.com)
  • AstraZeneca is ditching TC-5214, a drug candidate it licensed from US pharma company Targacept in 2009 under a deal worth up to $740 million, $200?million of which AstraZeneca paid up front. (chemistryworld.com)
  • Previously, he held senior medical positions at TransTech Pharma and NormOxys, two biotechnology companies focused on the development of drug candidates in a variety of therapeutic areas, including oncology, cardiovascular and neuroscience. (redchip.com)
Reproxalap5
  • If approved, reproxalap would be the first marketed RASP (reactive aldehyde species) modulator, representing a novel, systems-based pharmacology involving a family of small molecule targets that affect a broad array of protein mediators. (aldeyra.com)
  • In addition to dry eye disease, reproxalap is in late-stage development for allergic conjunctivitis, a condition that is commonly associated with dry eye disease. (aldeyra.com)
  • Reproxalap, an investigational new drug candidate, is a first-in-class small-molecule modulator of RASP (reactive aldehyde species), which are elevated in ocular and systemic inflammatory disease. (aldeyra.com)
  • Our pre-commercial product candidates are reproxalap, a potential treatment for dry eye disease and allergic conjunctivitis, and ADX-2191, a potential treatment for primary vitreoretinal lymphoma, proliferative vitreoretinopathy, and other rare sight-threatening retinal diseases. (aldeyra.com)
  • Multiple regulatory and clinical catalysts are planned for the coming quarters, including PDUFA dates for ADX-2191 and reproxalap, top-line results from our Phase 2 clinical trials in retinitis pigmentosa and chronic cough, and top-line results from our Phase 3 INVIGORATE-2 trial in allergic conjunctivitis. (chroniclejournal.com)
Investigational new drug candi1
  • ADX-629, an investigational new drug candidate, is a novel, orally administered RASP (reactive aldehyde species) modulator for the potential treatment of systemic immune-mediated diseases. (chroniclejournal.com)
Bacterial7
  • Furthermore, the escalating application of probiotic-based interventions, since they are designed to restore a healthy ocular microbiome and enhance the eye's natural defense mechanisms against bacteria, is expected to drive the bacterial conjunctivitis market during the forecast period. (imarcgroup.com)
  • IMARC Group's new report provides an exhaustive analysis of the bacterial conjunctivitis market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. (imarcgroup.com)
  • According to the report the United States has the largest patient pool for bacterial conjunctivitis and also represents the largest market for its treatment. (imarcgroup.com)
  • This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the bacterial conjunctivitis market in any manner. (imarcgroup.com)
  • This report also provides a detailed analysis of the current bacterial conjunctivitis marketed drugs and late-stage pipeline drugs. (imarcgroup.com)
  • The latest market report presented by Reports and Data, titled 'Global Bacterial Conjunctivitis Treatment Market ,' is inclusive of crucial data information pertaining to the global Bacterial Conjunctivitis Treatment market. (mynextmatch.com)
  • The global Bacterial Conjunctivitis Treatment market consists of various market players, which make this business sphere highly competitive. (mynextmatch.com)
Pandemic7
  • 2020 was [laughs] a terrible year, a really rough year to be promoting a new drug in the midst of the pandemic. (fool.com)
  • What is the impact of the COVID-19 pandemic on the market? (thepostrecords.com)
  • In the early stages of the pandemic, the COVID-19 outbreak had a negative impact on the market because fewer people went to the eye doctor. (market.us)
  • According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage. (mynextmatch.com)
  • The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. (businessresearchinsights.com)
  • The COVID-19 pandemic caused a disruption in all the industries and markets throughout the world. (businessresearchinsights.com)
  • The increase in the price of raw materials, non-availability of skilled workers were also some reasons that led to the fall of market share during the pandemic. (businessresearchinsights.com)
Dextenza4
  • The company has one drug on the market, Dextenza, which is the insert that goes into the eye that releases steroid for inflammation and pain, following eye surgery. (fool.com)
  • Net product revenue for Dextenza was up nearly 700% against the prior-year period and we achieved record quarterly in-market sales of nearly 25,000 billable units, representing a 50% sequential increase over the first quarter. (drugdeliverybusiness.com)
  • In 2020, Ocular entered into a licensing agreement with AffaMed Therapeutics for the development and commercialization of DEXTENZA ® in Greater China , South Korea , and the ASEAN markets. (ocutx.com)
  • Ocular Therapeutix retains the right to develop and commercialize DEXTENZA ® and OTX-TIC in all other global markets. (ocutx.com)
Antihistamine drugs2
  • Due to rising disposable income and shifting Route of Administration lifestyles, the market for antihistamine drugs will expand. (credenceresearch.com)
  • Due to the convenience and effectiveness of oral antihistamine drugs, this segment dominated the market with a 48.2 % market share. (forextv.com)
Ocular Therapeutix1
  • Ocular Therapeutix (NSDQ:OCUL) shares ticked up this morning on second-quarter results that topped revenue forecasts. (drugdeliverybusiness.com)
Share6
  • The Americas will account for the highest market share throughout the forecast period. (technavio.com)
  • This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. (imarcgroup.com)
  • There was a massive disruption in the demand-supply chain and equilibrium across all industries, especially in the chemical industry which brought down the polymixin market share. (businessresearchinsights.com)
  • Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. (futurewiseresearch.com)
  • Allergic Disorders in Anticipated to Hold a Significant Share in the Market Studied. (forextv.com)
  • Additionally, Mast cell stabilizers have a major share after Antihistamine in the Eye Allergy Therapeutics Market because Stabilizers are drugs that prevent allergic responses in the eyes by preventing mast cells from releasing inflammatory compounds like histamines. (verifiedmarketresearch.com)
Size1
  • The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. (semiconductorsindustry.com)
Factors3
  • Market Drivers of Rehabilitation Training Robotics: The key factors which influence the overall sales demand for Rehabilitation Training Robotics Industry in a positive way. (cognitivemarketresearch.com)
  • The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. (iposcoop.com)
  • Moreover, lack of skilled professionals, lack of awareness, and aide effects of many drugs are those factors that are hindering the development of the Global Eye Allergy Therapeutics Market. (verifiedmarketresearch.com)
Aldehyde3
  • We are excited to welcome Mary to the Aldeyra team and we look forward to utilizing her expertise in drug development as we continue to advance our aldehyde trap platform," commented Dr. Brady. (redchip.com)
  • The addition of Ms. Taylor further strengthens our ability to bring much needed treatment to market for a number of inflammatory diseases and inborn errors of aldehyde metabolism. (redchip.com)
  • His knowledge and leadership will be invaluable to the Company as we work to continue to advance potential therapies for aldehyde-related diseases toward the market, and we look forward to his contributions. (redchip.com)
LANDSCAPE1
  • According to a replacement report, the world " Electronic Manufacturing Services Market " 2029 provides a comprehensive assessment of the market landscape, encompassing each this and future standing of the market. (semiconductorsindustry.com)
Analysis2
  • The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation. (fool.com)
  • Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis. (semiconductorsindustry.com)
Treatment6
  • The drug received FDA approval for its current indication as a treatment for pain post-surgery. (fool.com)
  • That said", Mr Anido went on, "we are now ending a pivotal year…which featured the important conversion" from Xibrom, a twice-daily version of bromfenac, a non-steroidal anti-inflammatory drug for the treatment of ocular inflammation and pain after cataract surgery to once-a-day bromfenac, sold as Bromday. (pharmatimes.com)
  • The regulatory package includes activity ranging from within minutes of drug administration to up to 12 weeks of treatment, crossover and parallel-group clinical trial designs, and assessment in dry eye chamber challenge and natural environment settings. (aldeyra.com)
  • Paris, France and Tarrytown, N.Y. - September 16, 2017 - Sanofi and Regeneron Pharmaceuticals, Inc. announced today positive results from the Phase 3 CAFÉ study of Dupixent ® (dupilumab) in adults with moderate-to-severe atopic dermatitis (AD) who are inadequately controlled with or intolerant to the broad immunosuppressant drug cyclosporine A (CSA), or when this treatment is medically inadvisable. (sanofi.com)
  • Aldeyra continues to build a robust pipeline of novel drug candidates for the treatment of immune-mediated diseases," stated Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra. (chroniclejournal.com)
  • Among children HEU, 80.3% had foetal exposure to three-drug antiretroviral treatment, 18.7% to zidovudine only and 1.0% had no antiretroviral exposure. (bvsalud.org)
Challenges1
Ophthalmology1
  • AffaMed shares our vision of developing and commercializing innovative ophthalmology products, and we look forward to working with them to bring our innovative therapies to these global markets. (ocutx.com)
Outlook1
  • In addition to this, the inflating utilization of effective treatments, including antibiotic eye drops or ointments and, in severe cases, oral antibiotics, to alleviate the condition and curtail its progression, is also creating a positive outlook for the market. (imarcgroup.com)
Acute1
Development9
  • Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration (FDA) approved products. (wikipedia.org)
  • Numerous companies are trying to meet the medical needs for this condition by focusing more on drug development. (technavio.com)
  • Mary Taylor has over 30 years of drug development experience, most recently as Senior Vice President Regulatory Affairs and Quality at Civitas Therapeutics. (redchip.com)
  • Aldeyra is at an early stage of development and may not ever have any products that generate significant revenue. (redchip.com)
  • Shire will pay $100?million upfront and make further payments totalling up to $225?million if and when prearranged drug development milestones are reached. (chemistryworld.com)
  • It has several focusses, including development of CBD-based pharmaceutical and nutraceutical drugs, plants and oral health products. (cannin.com)
  • This company has additional risk in that 1) its products are in development and have not yet been proven to work enough to prove there a strong market. (cannin.com)
  • These are all revenues from third parties and do not include any development work on internal products being developed by Caladrius. (smithonstocks.com)
  • The FDA's Fast Track designation is a process designed to facilitate the development and expedite the review of drugs and vaccines for serious conditions and that fill an unmet medical need. (blogspot.com)
Outbreak of COVID-191
  • The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations travel bans and quarantines restaurants closed all indoor events restricted over forty countries state of emergency declared massive slowing of the IT Spending market volatility falling business confidence, growing panic among the population, and uncertainty about future. (thepostrecords.com)
PHARMACEUTICAL2
  • He went on to say the board "does recognise that volatile markets since July 2011 have put pressure on ISTA's stock price" and other specialty pharmaceutical companies. (pharmatimes.com)
  • BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited [TSE: 4502], ("Takeda") today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda's purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate. (blogspot.com)
Demand4
  • COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. (thepostrecords.com)
  • Digital transformation and industry 4.0 had boosted the demand for Electronic Manufacturing Services Market. (semiconductorsindustry.com)
  • Additionally, it is anticipated that rising anti-VEGF agent demand and usage, as well as the existence of significant market players with broad product portfolios, would all contribute to the segment's expansion. (cbinsights.com)
  • and (iv) the ability of manufacturers to increase distribution through pharmacies and expand export markets in the ASEAN region, where demand for medicines and vaccines remains strong. (pakgon.com)
Global5
  • We have various report editions of Rehabilitation Training Robotics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. (cognitivemarketresearch.com)
  • Based on disease, the global dry eye syndrome market is categorized into evaporative dry eye syndrome and aqueous deficient dry eye syndrome. (market.us)
  • It analyzes the competitive developments, such as alliance, joint venture, and merger & acquisition of the global market. (moneynewswire.net)
  • The Global Eye Allergy Therapeutics Market report provides a holistic evaluation of the market. (verifiedmarketresearch.com)
  • The Global Eye Allergy Therapeutics Market is segmented on the basis of Product, Distribution Channel, And Geography. (verifiedmarketresearch.com)
Commonly1
20203
  • That approval was received in mid-2019, so really 2020 was the primary year when the company began to truly launch that drug. (fool.com)
  • So I don't think we can make a fair assessment of Dextenza's potential based on the results in 2020, although the sales did increase for the drug. (fool.com)
  • Changes in year-to-date spending varied by type of service, with physician office revenue down 4.0% and hospital revenue down 1.7% by the third quarter of 2020 (relative to year-to-date spending as of third quarter in 2019). (kff.org)
Bepreve1
Therapies1
  • The preference of drug therapies for treating the disease will continue to increase due to the lack of skilled surgeons and pituitary surgical centers. (technavio.com)
Therapeutics2
  • Locking in on three in particular, each ticker boasts a "Strong Buy" consensus rating from the analyst community.Aquestive Therapeutics (AQST)Using its patented PharmFilm technology, Aquestive Therapeutics works to improve the delivery of approved drug active ingredients. (cedric-lachat.com)
  • The creation of a unified sector for ophthalmological therapy has given the worldwide Eye Allergy Therapeutics Market tremendous opportunities. (verifiedmarketresearch.com)
Tablets1
  • Lexapro tablets are marketed in the US by Forest, which developed escitalopram in partnership with Danish drugmaker Lundbeck. (chemistryworld.com)
Regulatory1
  • She has extensive experience with Investigational New Drug (IND) and New Drug Applications (NDA), and has managed multiple regulatory programs throughout her career. (redchip.com)
Product3
  • The product type segment is OTC Drugs and prescription drugs. (cbinsights.com)
  • Of note, VALTOCO orphan drug exclusivity approval may prevent a subsequent product approval (same active moiety as well as an indication) during the exclusivity period unless the new product can demonstrate 'clinical superiority' to the approved products," she explained.To this end, Moussatos remains optimistic and sees Libervant's approval as a major potential catalyst. (cedric-lachat.com)
  • With several product candidates currently under review at the FDA, it's no wonder Wall Street focus has zeroed in on this name.On September 16, ETON announced that its partner hadn't received any update from the FDA regarding its decision on the review of EM-100, its eye drop product for allergic conjunctivitis. (cedric-lachat.com)
Exclusivity2
  • The generic version will be marketed by Israeli generics giant Teva, which has a 180 day period of exclusivity. (chemistryworld.com)
  • Lundbeck was granted a separate patent for the latter, but critics said this was unreasonable given the similarity and accused the company of unfairly extending a period of exclusivity for a single drug. (chemistryworld.com)
Hospital Pharmacies1
  • Based on Application, The market is classified into Hospital Pharmacies, Online Pharmacy, and Drug Stores. (verifiedmarketresearch.com)
REPORT2
  • Our analysts can customize this market research report to meet your requirements. (technavio.com)
  • The report also provides the current and future patient pool across the seven major markets. (imarcgroup.com)
Primarily2
  • The market is primarily segmented on the basis of dose, type, material, and region. (polarismarketresearch.com)
  • Zika is caused by a virus transmitted primarily by Aedes aegypti mosquitoes.1 Symptoms of Zika may include mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache.1 According to the World Health Organization (WHO), Zika virus can cause serious birth defects called congenital Zika syndrome, including microcephaly.1 Zika is also a cause of an uncommon sickness of the peripheral nervous system called Guillain-Barré syndrome. (blogspot.com)
Patients2
  • Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins. (chemistryworld.com)
  • Conjunctivitis was more frequent in patients who received Dupixent with TCS, with 16 percent and 28 percent reported in patients who received Dupixent weekly or every two weeks with TCS, respectively, compared to 11 percent for patients who received placebo with TCS. (sanofi.com)
Expenditures1
  • In the users die from tobacco products, and smokers die an average of United States, marketing expenditures for cigarette advertising and 14 years earlier than nonsmokers ( 2,3 ). (cdc.gov)
Application3
  • Additionally, a number of research organizations are investigating the AR application market for a range of goods and uses. (semiconductorsindustry.com)
  • Rehabilitation Training Robotics market has been segmented with the help of its Type, Application , and others. (cognitivemarketresearch.com)
  • Takeda's Zika vaccine candidate is currently being studied in a Phase 1 trial (ZIK-101) under a U.S. Investigational New Drug (IND) application. (blogspot.com)